Mirati Therapeutics prices $56.88 million of stock at $17.50 per share

Jefferies, Leerink Swann are bookrunners for follow-on sale

New York, Oct. 23 - Mirati Therapeutics, Inc. priced $56.88 million of stock in a public follow-on offering at $17.50 per share.

The company sold 3.25 million shares via bookrunners Jefferies LLC and Leerink Swann LLC.

There is a greenshoe for a further 487,500 shares.

Proceeds will be used for research and development, working capital, potential future licensing or partnership transactions and other general corporate expenses.

Mirati is a San Diego-based oncology company.

Issuer:	Mirati Therapeutics, Inc.
Issue:	Common stock
Amount:	$56,875,000
Greenshoe:	$8,531,250 (487,500 shares)
Shares:	3,250,000
Price:	$17.50
Bookrunners:	Jefferies LLC, Leerink Swann LLC
Lead manager:	Piper Jaffray & Co.
Pricing date:	Oct. 23
Settlement:	Oct. 29
Distribution:	Registered
Stock symbol:	MRTX
Stock price:	$18.13 at close, Oct. 23
Market capitalization:	$180.57 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.